-
1
-
-
0141609055
-
Ebola virus: From discovery to vaccine
-
Feldmann, H., Jones, S., Klenk, H. D. & Schnittler, H. J. Ebola virus: from discovery to vaccine. Nat Rev Immunol 3, 677-685 (2003).
-
(2003)
Nat Rev Immunol
, vol.3
, pp. 677-685
-
-
Feldmann, H.1
Jones, S.2
Klenk, H.D.3
Schnittler, H.J.4
-
2
-
-
0029688564
-
Emerging and reemerging of filoviruses
-
Feldmann, H., Slenczka, W. & Klenk, H. D. Emerging and reemerging of filoviruses. Arch Virol [Suppl] 11, 77-100 (1996).
-
(1996)
Arch Virol Suppl
, vol.11
, pp. 77-100
-
-
Feldmann, H.1
Slenczka, W.2
Klenk, H.D.3
-
3
-
-
0032907635
-
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virusinfected patients
-
Baize, S. et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virusinfected patients. Nature Medicine 5, 423-426 (1999).
-
(1999)
Nature Medicine
, vol.5
, pp. 423-426
-
-
Baize, S.1
-
4
-
-
0034709761
-
Human asymptomatic Ebola infection and strong inflammatory response
-
Leroy, E. M. et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 355, 2210-2215 (2000).
-
(2000)
Lancet
, vol.355
, pp. 2210-2215
-
-
Leroy, E.M.1
-
5
-
-
77953351485
-
Ebola and marburg hemorrhagic fever
-
Hartman, A. L., Towner, J. S. & Nichol, S. T. Ebola and marburg hemorrhagic fever. Clinics in Laboratory Medicine 30, 161-177 (2010).
-
(2010)
Clinics in Laboratory Medicine
, vol.30
, pp. 161-177
-
-
Hartman, A.L.1
Towner, J.S.2
Nichol, S.T.3
-
6
-
-
0036100307
-
Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody
-
Parren, P. W. et al. Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J Viro l76(12), 6408-12 (2002).
-
(2002)
J Viro
, vol.176
, Issue.12
, pp. 6408-6412
-
-
Parren, P.W.1
-
7
-
-
33846490649
-
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys
-
Oswald, W. B. et al. Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLos Pathog 3(1), p. e9 (2007).
-
(2007)
PLos Pathog
, vol.3
, Issue.1
, pp. e9
-
-
Oswald, W.B.1
-
8
-
-
84859462127
-
Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
-
Dye, J. M. et al. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proc Natl Acad Sci USA 109(13), p. 5034-9 (2012).
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, Issue.13
, pp. 5034-5039
-
-
Dye, J.M.1
-
9
-
-
84907263545
-
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
-
Qiu, X. et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47-53 (2014).
-
(2014)
Nature
, vol.514
, pp. 47-53
-
-
Qiu, X.1
-
10
-
-
84912116176
-
Fighting Ebola with ZMapp: Spotlight on plant-made antibody
-
Zhang, Y., Li, D., Jin, X. & Huang, Z. Fighting Ebola with ZMapp: spotlight on plant-made antibody. Science China Life sciences 57, 987-988 (2014).
-
(2014)
Science China Life Sciences
, vol.57
, pp. 987-988
-
-
Zhang, Y.1
Li, D.2
Jin, X.3
Huang, Z.4
-
11
-
-
84862525229
-
Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies
-
138ra181
-
Qiu, X. et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med 4, 138ra181, doi: 10.1126/scitranslmed.3003876 (2012).
-
(2012)
Sci Transl Med
, vol.4
-
-
Qiu, X.1
-
12
-
-
84912064043
-
US signs contract with ZMapp maker to accelerate development of the Ebola drug
-
McCarthy, M. US signs contract with ZMapp maker to accelerate development of the Ebola drug. BMJ 349, doi: 10.1136/bmj.g5488. (2014).
-
(2014)
BMJ
, vol.349
-
-
McCarthy, M.1
-
13
-
-
0033062193
-
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee
-
Mupapa, K. et al. Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis 179 Suppl 1, S18-23 (1999).
-
(1999)
J Infect Dis
, vol.179
, pp. S18-S23
-
-
Mupapa, K.1
-
14
-
-
0033035994
-
Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: Determinants of survival
-
Sadek, R. F., Khan, A. S., Stevens, G., Peters, C. J. & Ksiazek, T. G. Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis 179 Suppl 1, S24-27 (1999).
-
(1999)
J Infect Dis
, vol.179
, pp. S24-S27
-
-
Sadek, R.F.1
Khan, A.S.2
Stevens, G.3
Peters, C.J.4
Ksiazek, T.G.5
-
15
-
-
77950219752
-
Hark back: Passive immunotherapy for influenza and other serious infections
-
Luke, T. C. et al. Hark back: passive immunotherapy for influenza and other serious infections. Crit Care Med 38 (4 Suppl), e66-73, doi: 10.1097/CCM.0b013e3181d44c1e (2010).
-
(2010)
Crit Care Med
, vol.38
, Issue.4
, pp. e66-e73
-
-
Luke, T.C.1
-
16
-
-
0034821759
-
Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases
-
Hemming, V. G. Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases. Clin Diagn Lab Immunol 8, 859-863 (2001).
-
(2001)
Clin Diagn Lab Immunol
, vol.8
, pp. 859-863
-
-
Hemming, V.G.1
-
17
-
-
84884925820
-
Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms
-
Leon, G. et al. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. Toxicon: Official Journal of the International Society on Toxinology 76, 63-76 (2013).
-
(2013)
Toxicon: Official Journal of the International Society on Toxinology
, vol.76
, pp. 63-76
-
-
Leon, G.1
-
18
-
-
0027053416
-
PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a phase I trial of hyperimmune porcine immunoglobulin to HIV-1
-
Osther, K. et al. PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a phase I trial of hyperimmune porcine immunoglobulin to HIV-1. Aids 6, 1457-1464 (1992).
-
(1992)
Aids
, vol.6
, pp. 1457-1464
-
-
Osther, K.1
-
19
-
-
84886259619
-
Physiological level production of antigen-specific human immunoglobulin in cloned transchromosomic cattle
-
Sano, A. et al. Physiological level production of antigen-specific human immunoglobulin in cloned transchromosomic cattle. Plos one 8, doi: 10.1371/journal.pone.0078119 (2013).
-
(2013)
Plos One
, vol.8
-
-
Sano, A.1
-
20
-
-
84897432390
-
Triple immunoglobulin gene knockout transchromosomic cattle: Bovine lambda cluster deletion and its effect on fully human polyclonal antibody production
-
Matsushita, H. et al. Triple immunoglobulin gene knockout transchromosomic cattle: bovine lambda cluster deletion and its effect on fully human polyclonal antibody production. Plos one 9, doi: 10.1371/journal.pone.0090383 (2014).
-
(2014)
Plos One
, vol.9
-
-
Matsushita, H.1
-
21
-
-
59849097833
-
Antigen-specific human polyclonal antibodies from hyperimmunized cattle
-
Kuroiwa, Y. et al. Antigen-specific human polyclonal antibodies from hyperimmunized cattle. Nat Biotechnol 27, 173-181 (2009).
-
(2009)
Nat Biotechnol
, vol.27
, pp. 173-181
-
-
Kuroiwa, Y.1
-
22
-
-
84939129686
-
Species-Specific Chromosome Engineering Greatly Improves Fully Human Polyclonal Antibody Production Profile in Cattle
-
Matsushita, H. et al. Species-Specific Chromosome Engineering Greatly Improves Fully Human Polyclonal Antibody Production Profile in Cattle. PLos One 10, doi: 10.1371/ journal.pone.0130699 (2015).
-
(2015)
PLos One
, vol.10
-
-
Matsushita, H.1
-
23
-
-
84914128755
-
DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome
-
264ra162
-
Hooper, J. W. et al. DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome. Sci Transl Med 6, 264ra162, doi: 10.1126/scitranslmed.3010082 (2014).
-
(2014)
Sci Transl Med
, vol.6
-
-
Hooper, J.W.1
-
24
-
-
82955233820
-
A shared structural solution for neutralizing ebolaviruses
-
Dias, J. M. et al. A shared structural solution for neutralizing ebolaviruses. Nat Struct Mol Biol 18, 1424-1427 (2011).
-
(2011)
Nat Struct Mol Biol
, vol.18
, pp. 1424-1427
-
-
Dias, J.M.1
-
25
-
-
85011081815
-
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine - Preliminary Report
-
April 1, 2015
-
Regules, J. A. et al. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine - Preliminary Report. N Engl J Med April 1, 2015, doi: 10.1056/NEJMoa1414216 (2015).
-
(2015)
N Engl J Med
-
-
Regules, J.A.1
-
26
-
-
77953009742
-
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus
-
15ra5
-
Khurana, S. et al. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci Transl Med 2, 15ra5, doi: 10.1126/scitranslmed.3000624 (2010).
-
(2010)
Sci Transl Med
, vol.2
-
-
Khurana, S.1
-
27
-
-
79957840765
-
MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
-
85ra48
-
Khurana, S. et al. MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines. Sci Transl Med 3, 85ra48, doi: 10.1126/scitranslmed.3002336 (2011).
-
(2011)
Sci Transl Med
, vol.3
-
-
Khurana, S.1
-
28
-
-
0034051595
-
Epitopes involved in antibody-mediated protection from Ebola virus
-
Wilson, J. A. et al. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287(5458), 1664-1666 (2000).
-
(2000)
Science
, vol.287
, Issue.5458
, pp. 1664-1666
-
-
Wilson, J.A.1
-
29
-
-
84859206023
-
Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection
-
Qiu, X. et al. Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection. PLos Negl Trop Dis 6(3), p. e1575, doi: 10.1371/journal.pntd.0001575 (2012).
-
(2012)
PLos Negl Trop Dis
, vol.6
, Issue.3
, pp. e1575
-
-
Qiu, X.1
-
30
-
-
84939448030
-
Rapid Manufacture and Release of a GMP Batch of Zaire Ebolavirus Glycoprotein Vaccine Made Using Recombinant Baculovirus-Sf9 Insect Cell Culture Technology
-
Hahn, T. J. et al. Rapid Manufacture and Release of a GMP Batch of Zaire Ebolavirus Glycoprotein Vaccine Made Using Recombinant Baculovirus-Sf9 Insect Cell Culture Technology. Bioprocessing Journal 14, 6-15 (2015).
-
(2015)
Bioprocessing Journal
, vol.14
, pp. 6-15
-
-
Hahn, T.J.1
-
31
-
-
84920797859
-
Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein
-
Martins, K. et al. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein. Viral Immunol 28(1), p. 62-70 (2015).
-
(2015)
Viral Immunol
, vol.28
, Issue.1
, pp. 62-70
-
-
Martins, K.1
-
32
-
-
0031688699
-
A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever
-
Bray, M. et al. A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 178(3), p. 651-61 (1998).
-
(1998)
J Infect Dis
, vol.178
, Issue.3
, pp. 651-661
-
-
Bray, M.1
|